Newsroom | 100377 results

CHAPEL HILL, N.C. & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--AESARA, a leading Value & Access agency, today announced that Denise Sánchez, JD, MS, MA, has joined the company as Vice President, Regulatory Counsel & Compliance Strategies. She served twice as FDA Regulatory Counsel for Policy—first at the Center for Biologics Evaluation and Research and later at the Center for Devices and Radiological Health—and brings more than 20 years of experience at the intersection of regulatory p...

LINKÖPING, Sweden--(BUSINESS WIRE)--HealthCap Invests in AMRA Medical to meet global demand for precise, scalable advanced muscle and fat imaging in clinical research and healthcare....

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health’s Feinstein Institutes for Medical Research aims to transform advanced care planning for older adults and those with Alzheimer’s disease and related dementias. The Feinstein Institutes secured a multi-year $8.9 million grant from the National Institutes of Health’s (NIH) National Institute on Aging (NIA) and will collaborate with Tufts University and Dartmouth Health to conduct the Advancing Ethical Goals in Society (AEGIS) clinical trial. This...

MADISON, Wis.--(BUSINESS WIRE)--Eurofins Supplement & OTC Testing and Eurofins Assurance are pleased to announce that the Eurofins Assurance Product Certification Program has received ISO/IEC 17065 accreditation from the American Association for Laboratory Accreditation (A2LA). The accredited scope includes certification of dietary supplements and dietary ingredients, as well as certification of conventional foods, fortified foods, and functional foods under the Eurofins Assurance Certified...

ROCHESTER, Minn.--(BUSINESS WIRE)--Vyriad begins Phase 1 clinical trial of VV169, an in vivo CAR T therapy for multiple myeloma, now open for enrollment at Mayo Clinic....

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biomunex announces the upcoming start of clinical development of IPN60330, the first MAIT engager, a new therapeutic class in oncology...

FALLS CHURCH, Va.--(BUSINESS WIRE)--Retension Pharmaceuticals, Inc. (“Retension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases, today announced the formation of its Scientific Advisory Board (SAB). The SAB is expected to provide strategic guidance as well as scientific, clinical trial, and therapeutic area expertise as Retension advances RTN-001 in clinical development in the ongoi...

SAN FRANCISCO--(BUSINESS WIRE)--SonoThera Appoints Adam J. Shaywitz, M.D., Ph.D., as Chief Medical Officer...

SAN FRANCISCO--(BUSINESS WIRE)--Shennon Biotechnologies Raises $12M in Financing, Appoints Cyril Konto, M.D., as Chief Executive Officer and Unveils Precision Immunotherapy Pipeline...

EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reiterates details of its upcoming Investor & Analyst Day, to be held on October 6, 2026, in Emeryville, CA. The event will feature presentations from OmniAb’s executive leadership team, including corporate updates, select partner programs, the xPloration® platform, technology innovations and a Q&A sessi...